Skip to content

International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25)

Fostering Global Interdisciplinary Collaboration for Sustainable Innovation in Drug Discovery and Translational Medicine

Venue: Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor
Date: 24-25 November (Pre-Conference Workshops) & 26-27 November 2025 (ICDDTM'25 Conference)
Menu
  • Home
    • Welcome and Selamat Datang
    • Committee Members
    • Gallery
    • The Venue
      • Nearby Hotels
  • Programme Schedule
    • Programme Schedule
    • Why You Should Attend
    • Plenary & Invited Speakers
    • Pre-Conference Workshops
      • Pharmacometrics
      • Conducting Clinical Trials
      • AI and Machine Learning in Drug Discovery: From Target Identification to Personalised Medicine
      • Network Pharmacology
      • All Topics
    • Special Forums
    • ICDDTM’25 Posters
  • Register
  • Submit Abstract
    • Author’s Guideline
      For Abstract
      • General Guidelines For Oral Presentation
      • General Guidelines For Poster Presentation
    • Awards
      • Travel Awards
  • Contact
  • F.A.Q.
  • Be A Sponsor
Menu

Prof. Dr Karolien De Bosscher

 

Prof. Dr Karolien De Bosscher
Nuclear Receptor Signalling
Ghent University, Belgium

———————————————————————-

Professor Dr Karolien De Bosscher, a molecular biologist, earned her Ph.D. from UGent in 2000. Following postdoctoral research at Cancer Research UK with an EMBO fellowship she returned to Belgium to conduct nuclear receptor research as a postdoctoral fellow of FWO-Vlaanderen. In 2013, she secured a research professorship, combining research and teaching at UGent. From 2019 onwards, she is a full professor at UGent and principal investigator at the VIB Center for Medical Biotechnology.

Throughout her career, Dr. De Bosscher focused on unraveling nuclear receptor intricacies, exploring anti-inflammatory and anti-cancer mechanisms. Her team investigates selective glucocorticoid receptor modulation, metabolic actions of nuclear receptors, and crosstalk mechanisms in hematological cancers. Dr. De Bosscher’s lab decodes how nuclear receptors transduce signals, aiming to innovate receptor-targeting strategies for enhanced therapeutic benefits. The team develops cell-based tools to capture nuclear receptors’ complexity, contributing to drug discovery platforms.

Note: Click [x] on top-right or anywhere on this pop-up to exit

 

Category:

Venue:
Hospital Sultan Abdul Aziz Shah (HSAAS), Universiti Putra Malaysia (UPM), Serdang, Selangor

ICDDTM'25 Flyer

Right click and Save As ICDDTM'25 Poster

All abstracts will be published in an indexed (Scopus or WoS) journal

Disclaimer

The information on this website is regularly updated to reflect the latest developments. While we strive for accuracy, details may change without prior notice.

All claims on the advertisements stated in this website are those of the vendors and journals and do not reflect the official position or endorsement from the organisers of ICDDTM'25. The organisers of ICDDTM'25 acknowledge the importance of having research data to substantiate all advertisement claims, and the research or citation is to be made available on the vendors’ and journals’ website or, where proprietary interests exist, be made available upon request.

Flag Counter
(Dr. D Y. Patil Dnyan Prasad University, Pune, India)
(Nirma University, India)
(University of Asia Pacific, Bangladesh)
(University of Gajah Mada, Indonesia)
(Birla Institute of Technology Mesra, India)
(The Halifax Institute, Canada)
(Jashore University of Science and Technology, Bangladesh)
(Yantai Affiliated Hospital of Binzhou Medical University, China)
(Universitas Andalas, Padang, Indonesia)
(Dhaka University, Bangladesh)
© 2025 International Conference on Drug Discovery and Translational Medicine 2025 (ICDDTM'25) | Organised by Malaysian Association for Cancer Research